Clinical Study of Chimeric HER-2 Antigen Receptor-modified T Cells in Chemotherapy Refractory HER-2 Advanced Solid Tumors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs HER2-CAR transduced T-cells (Primary)
- Indications Breast cancer; Endometrial cancer; Gastric cancer; Liver cancer; Non-small cell lung cancer; Ovarian cancer; Solid tumours
- Focus Adverse reactions
- Acronyms CART-HER2
- 28 Jan 2016 Biomarkers information updated
- 03 Oct 2013 New trial record